Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potent, selective proteasome compounds derived from belactosin

Dec. 22, 2000

York Medical changes name, reports pipeline progress

Dec. 22, 2000

Protein farnesyltransferase inhibitors useful for cancer therapy patented by BMS

Dec. 21, 2000

Faslodex highlighted at Breast Cancer Symposium as a novel approach to postmenopausal breast cancer

Dec. 21, 2000

Results from ongoing phase II trial of 9-NC in metastatic breast cancer reported in San Antonio

Dec. 21, 2000

SD/01 is equally effective and safe as once-daily filgrastim over multiple cycles of chemotherapy

Dec. 21, 2000

Dolastatin 10 has no significant efficacy in advanced breast cancer

Dec. 21, 2000

Exclusive rights to nucleoside analogue acquired from SRI by Gilead

Dec. 21, 2000

Bayer designs improved camptothecin derivatives for cancer therapy

Dec. 20, 2000

Antisense compounds from Isis modulate PPARgamma expression

Dec. 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.